{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:36:11Z","timestamp":1782959771709,"version":"3.54.5"},"reference-count":302,"publisher":"Elsevier","isbn-type":[{"value":"9780128244159","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.acc.2020.06.005","type":"book-chapter","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T17:04:07Z","timestamp":1595264647000},"page":"41-93","source":"Crossref","is-referenced-by-count":17,"title":["Parathyroid hormone"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF01574261","article-title":"Human parathyroid hormone gene (PTH) is on short arm of chromosome 11","volume":"9","author":"Naylor","year":"1983","journal-title":"Somatic Cell Genet."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ecl.2018.07.003","article-title":"Physiology of parathyroid hormone","volume":"47","author":"Goltzman","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-56-3-572","article-title":"Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue","volume":"56","author":"Brown","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0025","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/endo-104-6-1778","article-title":"Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood","volume":"104","author":"Mayer","year":"1979","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/jcem-63-5-1075","article-title":"Calcium-dependent release of carboxyl-terminal fragments of parathyroid hormone by hyperplastic human parathyroid tissue in vitro","volume":"63","author":"Hanley","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0035","first-page":"525","article-title":"The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration","volume":"74","author":"D'Amour","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0040","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/endo-99-6-1645","article-title":"Metabolism of radioiodinated bovine parathyroid hormone in the rat","volume":"99","author":"Segre","year":"1976","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0045","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1021\/ac051711o","article-title":"Identification of carboxyl-terminal peptide fragments of parathyroid hormone in human plasma at low-picomolar levels by mass spectrometry","volume":"78","author":"Zhang","year":"2006","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI110052","article-title":"Effects of hepatectomy, nephrectomy, and nephrectomy\/uremia on the metabolism of parathyroid hormone in the rat","volume":"67","author":"Segre","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1172\/JCI113946","article-title":"Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat","volume":"83","author":"Yamamoto","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI114840","article-title":"Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat","volume":"86","author":"Naveh-Many","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0065","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1074\/jbc.M005471200","article-title":"A conserved cis-acting element in the parathyroid hormone 3\u2032-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate","volume":"276","author":"Kilav","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/endo-125-2-935","article-title":"Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells","volume":"125","author":"Kremer","year":"1989","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0075","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene","volume":"119","author":"Russell","year":"1986","journal-title":"Endocrinology"},{"issue":"46","key":"10.1016\/bs.acc.2020.06.005_bb0080","doi-asserted-by":"crossref","first-page":"18827","DOI":"10.1073\/pnas.1210037109","article-title":"Vitamin D receptor as a master regulator of the c-MYC\/MXD1 network","volume":"109","author":"Salehi-Tabar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0085","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1016\/S0021-9258(18)32406-2","article-title":"Similarities of Li+ and low Ca2+ in the modulation of secretion by parathyroid cells in vitro","volume":"258","author":"Wallace","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"1\u20135","key":"10.1016\/bs.acc.2020.06.005_bb0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jsbmb.2004.03.061","article-title":"1,25-Dihydroxyvitamin D downregulation of TGFalpha\/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure","volume":"89\u201390","author":"Dusso","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0095","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1210\/en.2004-0734","article-title":"Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?","volume":"146","author":"Xu","year":"2005","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00774-008-0032-8","article-title":"Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period","volume":"27","author":"Nakajima","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/bs.acc.2020.06.005_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/978-1-4614-0887-1_6","article-title":"FGF23 and the parathyroid","volume":"728","author":"Silver","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0110","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0115","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0120","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/endo.132.6.8389284","article-title":"Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids","volume":"132","author":"Russell","year":"1993","journal-title":"Endocrinology"},{"issue":"17","key":"10.1016\/bs.acc.2020.06.005_bb0125","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3","volume":"89","author":"Demay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1989.3","article-title":"1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs","volume":"35","author":"Brown","year":"1989","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/endo-125-1-275","article-title":"Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D","volume":"125","author":"Naveh-Many","year":"1989","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ndt\/14.4.811","article-title":"Protein-RNA interactions in the regulation of PTH gene expression by calcium and phosphate","volume":"14","author":"Naveh-Many","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0014-5793(02)03259-3","article-title":"Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate","volume":"529","author":"Naveh-Many","year":"2002","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0150","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","article-title":"RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate","volume":"273","author":"Moallem","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1677\/jme.0.0100043","article-title":"Post-transcriptional regulation of bovine parathyroid hormone synthesis","volume":"10","author":"Hawa","year":"1993","journal-title":"J. Mol. Endocrinol."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0160","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jbmr.5650110605","article-title":"Translational regulation of parathyroid hormone gene expression and RNA: protein interactions","volume":"11","author":"Vadher","year":"1996","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/cr.2007.54","article-title":"Systems perspectives on mRNA processing","volume":"17","author":"McKee","year":"2007","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ceb.2005.04.006","article-title":"Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors","volume":"17","author":"Bentley","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2006.06.023","article-title":"Alternative splicing: new insights from global analyses","volume":"126","author":"Blencowe","year":"2006","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0180","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1261\/rna.7100104","article-title":"Multiple links between transcription and splicing","volume":"10","author":"Kornblihtt","year":"2004","journal-title":"RNA"},{"issue":"23","key":"10.1016\/bs.acc.2020.06.005_bb0185","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1101\/gad.1256904","article-title":"A systems view of mRNP biology","volume":"18","author":"Hieronymus","year":"2004","journal-title":"Genes Dev."},{"issue":"5740","key":"10.1016\/bs.acc.2020.06.005_bb0190","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1111443","article-title":"From birth to death: the complex lives of eukaryotic mRNAs","volume":"309","author":"Moore","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/rna.3.3.3373","article-title":"Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era","volume":"3","author":"Sanchez-Diaz","year":"2006","journal-title":"RNA Biol."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nsmb961","article-title":"Building specificity with nonspecific RNA-binding proteins","volume":"12","author":"Singh","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7224","key":"10.1016\/bs.acc.2020.06.005_bb0205","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature07480","article-title":"Endonucleolytic RNA cleavage by a eukaryotic exosome","volume":"456","author":"Lebreton","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nsmb.1556","article-title":"A complex gene regulatory mechanism that operates at the nexus of multiple RNA processing decisions","volume":"16","author":"McPheeters","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/bs.acc.2020.06.005_bb0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0076-6879(08)02611-6","article-title":"Biochemical studies of the mammalian exosome with intact cells","volume":"448","author":"Schilders","year":"2008","journal-title":"Methods Enzymol."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0220","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1096\/fj.08-107250","article-title":"The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels","volume":"22","author":"Nechama","year":"2008","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0225","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1172\/JCI39522","article-title":"The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism","volume":"119","author":"Nechama","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0230","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1172\/JCI40784","article-title":"Pin1 regulates parathyroid hormone mRNA stability","volume":"119","author":"Kumar","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0240","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/endo-93-6-1349","article-title":"Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity","volume":"93","author":"Tregear","year":"1973","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0245","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/S0021-9258(19)41611-6","article-title":"Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues","volume":"250","author":"Goltzman","year":"1975","journal-title":"J. Biol. Chem."},{"issue":"5034","key":"10.1016\/bs.acc.2020.06.005_bb0250","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"Juppner","year":"1991","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0255","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0265","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0270","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/en.2004-1283","article-title":"G alpha12\/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells","volume":"146","author":"Singh","year":"2005","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0275","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1359\/JBMR.040806","article-title":"Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells","volume":"19","author":"Radeff","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"42","key":"10.1016\/bs.acc.2020.06.005_bb0280","doi-asserted-by":"crossref","first-page":"29968","DOI":"10.1074\/jbc.274.42.29968","article-title":"Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy","volume":"274","author":"Ferrari","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0285","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/187153011795564151","article-title":"Beta-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption","volume":"11","author":"Bohinc","year":"2011","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"44","key":"10.1016\/bs.acc.2020.06.005_bb0290","doi-asserted-by":"crossref","first-page":"43787","DOI":"10.1074\/jbc.M306019200","article-title":"Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50)","volume":"278","author":"Sneddon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/bs.acc.2020.06.005_bb0295","doi-asserted-by":"crossref","first-page":"26976","DOI":"10.1074\/jbc.M110.147785","article-title":"Na\/H exchanger regulatory factors control parathyroid hormone receptor signaling by facilitating differential activation of G(alpha) protein subunits","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6891","key":"10.1016\/bs.acc.2020.06.005_bb0300","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nature00816","article-title":"Na(+)\/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling","volume":"417","author":"Mahon","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0305","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1210\/endo.137.8.8754733","article-title":"Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH\/PTHrP receptors in vascular smooth muscle cells","volume":"137","author":"Maeda","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2020.06.005_bb0310","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.physiol.65.042902.092424","article-title":"Regulation of Na\/Pi transporter in the proximal tubule","volume":"65","author":"Murer","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0315","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1073\/pnas.95.4.1387","article-title":"Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter","volume":"95","author":"Brenza","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5 Pt. 2","key":"10.1016\/bs.acc.2020.06.005_bb0320","first-page":"F767","article-title":"Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry","volume":"266","author":"Custer","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/endo.138.1.4845","article-title":"Cell-specific expression of the parathyroid hormone (PTH)\/PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promoters","volume":"138","author":"Amizuka","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0330","doi-asserted-by":"crossref","first-page":"F1233","DOI":"10.1152\/ajprenal.00249.2003","article-title":"Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport","volume":"285","author":"Ba","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0335","doi-asserted-by":"crossref","first-page":"C927","DOI":"10.1152\/ajpcell.00126.2006","article-title":"Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+\u2212phosphate cotransporter NaPi-IIa in Nherf1-deficient mice","volume":"292","author":"Capuano","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0340","doi-asserted-by":"crossref","first-page":"F792","DOI":"10.1152\/ajprenal.2000.278.5.F792","article-title":"Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-P(i) cotransporter","volume":"278","author":"Traebert","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0345","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.ki.5000148","article-title":"The renal Na+\/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone","volume":"69","author":"Bacic","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0350","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1152\/ajprenal.00100.2006","article-title":"Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter","volume":"292","author":"Segawa","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0355","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1172\/JCI106458","article-title":"Effects of parathyroid hormone on plasma and urinary adenosine 3\u2032,5\u2032-monophosphate in man","volume":"49","author":"Kaminsky","year":"1970","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0360","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00581759","article-title":"Active Ca2+ reabsorption in the proximal tubule of the rat kidney. Dependence on sodium- and buffer transport","volume":"364","author":"Ullrich","year":"1976","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0365","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/ki.1996.539","article-title":"Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney","volume":"50","author":"Hebert","year":"1996","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0370","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1681\/ASN.2012030323","article-title":"Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria","volume":"23","author":"Toka","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0375","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI57407","article-title":"PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor","volume":"122","author":"Loupy","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0380","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1523-1755.2005.00587.x","article-title":"Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone","volume":"68","author":"van Abel","year":"2005","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0385","doi-asserted-by":"crossref","first-page":"F1212","DOI":"10.1152\/ajprenal.00007.2008","article-title":"Protein kinase C inhibits caveolae-mediated endocytosis of TRPV5","volume":"294","author":"Cha","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0390","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ceca.2008.12.003","article-title":"Activation of the Ca2+-sensing receptor stimulates the activity of the epithelial Ca2+ channel TRPV5","volume":"45","author":"Topala","year":"2009","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0395","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00424-009-0657-z","article-title":"Regulated acid-base transport in the collecting duct","volume":"458","author":"Wagner","year":"2009","journal-title":"Pflugers Arch."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650051008","article-title":"Characterization of the major parathyroid hormone target cell in the endosteal metaphysis of rat long bones","volume":"5","author":"Rouleau","year":"1990","journal-title":"J. Bone Miner. Res."},{"issue":"6937","key":"10.1016\/bs.acc.2020.06.005_bb0405","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"45","key":"10.1016\/bs.acc.2020.06.005_bb0410","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0415","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","article-title":"Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone","volume":"40","author":"Yang","year":"2007","journal-title":"Bone"},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0420","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1210\/en.2009-1494","article-title":"Phospholipase C signaling via the parathyroid hormone (PTH)\/PTH-related peptide receptor is essential for normal bone responses to PTH","volume":"151","author":"Guo","year":"2010","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0425","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI0214817","article-title":"Parathyroid hormone is essential for normal fetal bone formation","volume":"109","author":"Miao","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023060","article-title":"Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34)","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0435","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0440","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/jbmr.2000","article-title":"Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation","volume":"28","author":"Zhu","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"51","key":"10.1016\/bs.acc.2020.06.005_bb0445","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1073\/pnas.0805690105","article-title":"Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein","volume":"105","author":"Miao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0450","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1096\/fj.09-147033","article-title":"The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice","volume":"24","author":"Toribio","year":"2010","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0455","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1210\/endo.138.12.5587","article-title":"Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells","volume":"138","author":"McCauley","year":"1997","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0460","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1074\/jbc.M007400200","article-title":"Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent","volume":"276","author":"Swarthout","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/bs.acc.2020.06.005_bb0465","doi-asserted-by":"crossref","first-page":"32204","DOI":"10.1074\/jbc.M101084200","article-title":"Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras\/mitogen-activated protein kinase signaling pathway","volume":"276","author":"Miao","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0470","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/me.2002-0225","article-title":"Parathyroid hormone bone anabolic action requires Cbfa1\/Runx2-dependent signaling","volume":"17","author":"Krishnan","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0475","doi-asserted-by":"crossref","first-page":"9787","DOI":"10.1074\/jbc.M110.179127","article-title":"Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway","volume":"286","author":"Hisa","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0480","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1074\/jbc.M409846200","article-title":"Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase","volume":"280","author":"Qin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0485","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/endo.138.5.5146","article-title":"Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone","volume":"138","author":"Onishi","year":"1997","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0490","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cellsig.2009.10.017","article-title":"Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation","volume":"22","author":"Datta","year":"2010","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0495","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0500","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bone.2009.05.006","article-title":"Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair","volume":"45","author":"Schnoke","year":"2009","journal-title":"Bone"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0505","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0510","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0515","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0520","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jbmr.53","article-title":"Building bone with a SOST-PTH partnership","volume":"25","author":"Sims","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0525","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tem.2009.12.002","article-title":"Does osteocytic SOST suppression mediate PTH bone anabolism?","volume":"21","author":"Kramer","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0530","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1210\/endo-124-3-1247","article-title":"Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone","volume":"124","author":"McCarthy","year":"1989","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0535","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2006.01.044","article-title":"Impaired bone anabolic response to parathyroid hormone in Fgf2\u2212\/\u2212 and Fgf2+\/\u2212 mice","volume":"341","author":"Hurley","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0540","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0545","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s001980070111","article-title":"Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis","volume":"11","author":"Lane","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0550","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/bs.acc.2020.06.005_bb0555","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2165\/00003495-200565170-00005","article-title":"Parathyroid hormone as an anabolic skeletal therapy","volume":"65","author":"Rubin","year":"2005","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/bs.acc.2020.06.005_bb0560","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-006-9007-z","article-title":"The use of parathyroid hormone in the treatment of osteoporosis","volume":"7","author":"Girotra","year":"2006","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0565","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.bone.2006.09.008","article-title":"Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure","volume":"40","author":"Compston","year":"2007","journal-title":"Bone"},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0570","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1359\/jbmr.070104","article-title":"Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium","volume":"22","author":"Lindsay","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0575","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1185\/03007995.2010.524121","article-title":"Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study","volume":"26","author":"Zanchetta","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0580","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0585","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0590","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcb.10490","article-title":"Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone","volume":"89","author":"Locklin","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/bs.acc.2020.06.005_bb0595","first-page":"137","article-title":"The effects of TGF-beta on bone","volume":"157","author":"Mundy","year":"1991","journal-title":"Ciba Found. Symp."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0600","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab."},{"issue":"52","key":"10.1016\/bs.acc.2020.06.005_bb0610","doi-asserted-by":"crossref","first-page":"20764","DOI":"10.1073\/pnas.0805133106","article-title":"Regulation of bone formation by osteoclasts involves Wnt\/BMP signaling and the chemokine sphingosine-1-phosphate","volume":"105","author":"Pederson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0615","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0620","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ydbio.2007.02.014","article-title":"Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid\/thymus primordia","volume":"305","author":"Liu","year":"2007","journal-title":"Dev. Biol."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0625","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/hmg\/ddq084","article-title":"Identification and characterization of novel parathyroid-specific transcription factor glial cells missing homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism","volume":"19","author":"Bowl","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0630","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/humu.20827","article-title":"Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism","volume":"30","author":"Canaff","year":"2009","journal-title":"Hum. Mutat."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0635","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1210\/jc.2009-2532","article-title":"A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism","volume":"95","author":"Mirczuk","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0640","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/jc.2003-030733","article-title":"Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin","volume":"89","author":"Maret","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0645","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0650","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1172\/JCI24156","article-title":"An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism","volume":"115","author":"Bowl","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0655","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3476(05)81740-8","article-title":"Variable phenotypes in velocardiofacial syndrome with chromosomal deletion","volume":"123","author":"Motzkin","year":"1993","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0660","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ajmg.1320450307","article-title":"Velo-cardio-facial syndrome: a review of 120 patients","volume":"45","author":"Goldberg","year":"1993","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0665","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3476(96)70372-4","article-title":"Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion","volume":"128","author":"Greig","year":"1996","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0670","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ecl.2018.07.007","article-title":"Genetic disorders of parathyroid development and function","volume":"47","author":"Gordon","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0675","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.CIR.93.9.1702","article-title":"Latent hypoparathyroidism in children with conotruncal cardiac defects","volume":"93","author":"Cuneo","year":"1996","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0680","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/ped.12665","article-title":"Clinical manifestations and frequency of hypocalcemia in 22q11.2 deletion syndrome","volume":"57","author":"Fujii","year":"2015","journal-title":"Pediatr. Int."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0685","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng1407","article-title":"Mutations in a new member of the chromodomain gene family cause CHARGE syndrome","volume":"36","author":"Vissers","year":"2004","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0690","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpeds.2005.10.044","article-title":"Phenotypic spectrum of CHARGE syndrome with CHD7 mutations","volume":"148","author":"Aramaki","year":"2006","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0695","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2003.017640","article-title":"SEMA3E mutation in a patient with CHARGE syndrome","volume":"41","author":"Lalani","year":"2004","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0700","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1542\/peds.2008-3400","article-title":"CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies\/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features","volume":"123","author":"Jyonouchi","year":"2009","journal-title":"Pediatrics"},{"issue":"6794","key":"10.1016\/bs.acc.2020.06.005_bb0705","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/35019088","article-title":"GATA3 haplo-insufficiency causes human HDR syndrome","volume":"406","author":"Van Esch","year":"2000","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0710","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jmg.38.6.374","article-title":"GATA3 abnormalities and the phenotypic spectrum of HDR syndrome","volume":"38","author":"Muroya","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/bs.acc.2020.06.005_bb0715","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2015.04.018","article-title":"Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1","volume":"411","author":"Han","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0720","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/adc.66.2.193","article-title":"A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features","volume":"66","author":"Sanjad","year":"1991","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0725","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/301915","article-title":"Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43","volume":"63","author":"Parvari","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0730","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<48::AID-AJMG9>3.0.CO;2-Y","article-title":"Sanjad-Sakati and autosomal recessive Kenny-Caffey syndromes are allelic: evidence for an ancestral founder mutation and locus refinement","volume":"85","author":"Diaz","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0735","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ajmg.1320420123","article-title":"Kenny-Caffey syndrome in two sibs born to consanguineous parents: evidence for an autosomal recessive variant","volume":"42","author":"Franceschini","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0740","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ajhg.2013.04.020","article-title":"FAM111A mutations result in hypoparathyroidism and impaired skeletal development","volume":"92","author":"Unger","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0745","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/hmg\/2.12.2081","article-title":"A new point mutation associated with mitochondrial encephalomyopathy","volume":"2","author":"Morten","year":"1993","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0750","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-3476(97)70111-2","article-title":"Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation","volume":"131","author":"Tyni","year":"1997","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0755","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3476(96)70206-8","article-title":"Hypoparathyroidism in mitochondrial trifunctional protein deficiency","volume":"129","author":"Dionisi-Vici","year":"1996","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0760","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1515\/JPEM.2009.22.12.1175","article-title":"Hypoketotic hypoglycemia with myolysis and hypoparathyroidism: an unusual association in medium chain acyl-CoA desydrogenase deficiency (MCADD)","volume":"22","author":"Baruteau","year":"2009","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0765","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI114811","article-title":"Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism","volume":"86","author":"Arnold","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0770","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1074\/jbc.270.4.1629","article-title":"Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein","volume":"270","author":"Karaplis","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0775","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/jc.2017-00250","article-title":"Autosomal dominant PTH gene signal sequence mutation in a family with familial isolated hypoparathyroidism","volume":"102","author":"Cinque","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"50","key":"10.1016\/bs.acc.2020.06.005_bb0780","doi-asserted-by":"crossref","first-page":"19989","DOI":"10.1073\/pnas.0708725104","article-title":"Signal sequence mutation in autosomal dominant form of hypoparathyroidism induces apoptosis that is corrected by a chemical chaperone","volume":"104","author":"Datta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0785","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1210\/jc.2013-2158","article-title":"Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism","volume":"98","author":"Tomar","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0790","first-page":"3792","article-title":"A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism","volume":"84","author":"Sunthornthepvarakul","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0795","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2012.06.009","article-title":"A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism","volume":"51","author":"Ertl","year":"2012","journal-title":"Bone"},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0800","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0592-149","article-title":"A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism","volume":"1","author":"Parkinson","year":"1992","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb0805","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2532","article-title":"A homozygous [Cys25]PTH(1-84) mutation that impairs PTH\/PTHrP receptor activation defines a novel form of hypoparathyroidism","volume":"30","author":"Lee","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0810","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat. Genet."},{"issue":"15","key":"10.1016\/bs.acc.2020.06.005_bb0815","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/bs.acc.2020.06.005_bb0820","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0825","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0830","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jbmr.2797","article-title":"Identification of a G-protein subunit-alpha11 gain-of-function mutation, Val340Met, in a family with autosomal dominant hypocalcemia type 2 (ADH2)","volume":"31","author":"Piret","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2020.06.005_bb0835","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb0840","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","article-title":"Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism","volume":"5","author":"Baron","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0845","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s100380170124","article-title":"A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia","volume":"46","author":"Hirai","year":"2001","journal-title":"J. Hum. Genet."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0850","first-page":"2497","article-title":"Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor","volume":"83","author":"Watanabe","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0855","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.87.3.1309","article-title":"Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia","volume":"87","author":"D'Souza-Li","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb0860","first-page":"2710","article-title":"Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor","volume":"82","author":"De Luca","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0865","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J. Mol. Endocrinol."},{"issue":"7 Suppl","key":"10.1016\/bs.acc.2020.06.005_bb0870","doi-asserted-by":"crossref","first-page":"1965S","DOI":"10.1093\/jn\/125.suppl_7.1965S","article-title":"The cloning of extracellular Ca(2+)-sensing receptors from parathyroid and kidney: molecular mechanisms of extracellular Ca(2+)-sensing","volume":"125","author":"Brown","year":"1995","journal-title":"J. Nutr."},{"issue":"18","key":"10.1016\/bs.acc.2020.06.005_bb0875","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0880","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0885","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0890","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ecl.2018.07.001","article-title":"Signs and symptoms of hypoparathyroidism","volume":"47","author":"Cusano","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/bs.acc.2020.06.005_bb0895","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2015.02.021","article-title":"Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia","volume":"407","author":"Baran","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0900","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0905","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb0910","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jbmr.3328","article-title":"Bone status among patients with nonsurgical hypoparathyroidism, autosomal dominant hypocalcaemia, and pseudohypoparathyroidism: a cohort study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/bs.acc.2020.06.005_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6823-13-1","article-title":"Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density","volume":"13","author":"Mendonca","year":"2013","journal-title":"BMC Endocr. Disord."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0920","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb0925","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0930","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb0935","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb0940","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0945","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-016-0767-6","article-title":"Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status","volume":"35","author":"Saha","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/bs.acc.2020.06.005_bb0950","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fphys.2018.00701","article-title":"Dental findings in patients with non-surgical hypoparathyroidism and pseudohypoparathyroidism: a systematic review","volume":"9","author":"Hejlesen","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0955","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ecl.2018.07.010","article-title":"Quality of life in hypoparathyroidism","volume":"47","author":"Vokes","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/bs.acc.2020.06.005_bb0960","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1038\/nrdp.2017.80","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0965","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2018.07.005","article-title":"Surgical hypoparathyroidism","volume":"47","author":"Kazaure","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0970","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2017.0309","article-title":"American thyroid association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults","volume":"28","author":"Orloff","year":"2018","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb0975","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF03350718","article-title":"Late-onset hypocalcemia appearing years after thyroid surgery","volume":"12","author":"Halperin","year":"1989","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb0980","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ecl.2018.07.012","article-title":"Conventional treatment of hypoparathyroidism","volume":"47","author":"Babey","year":"2018","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb0985","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2015-2257","article-title":"The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study","volume":"100","author":"Levy","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb0990","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb0995","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective six year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1000","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1005","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1010","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","article-title":"Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study","volume":"55","author":"Clarke","year":"2017","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1020","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.3543","article-title":"The effects of long-term administration of rhPTH(1-84) in hypoparathyroidism by bone histomorphometry","volume":"33","author":"Rubin","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1025","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.2555","article-title":"Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism","volume":"30","author":"Gafni","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1035","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1040","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","article-title":"Six hundred fifty-six consecutive explorations for primary hyperparathyroidism","volume":"235","author":"Udelsman","year":"2002","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1050","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","article-title":"The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center","volume":"98","author":"Zhao","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00268-007-9384-9","article-title":"Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency","volume":"32","author":"Pradeep","year":"2008","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb1065","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1075","first-page":"4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/bs.acc.2020.06.005_bb1080","first-page":"N103","article-title":"Fracture risk in primary hyperparathyroidism","volume":"17","author":"Khosla","year":"2002","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J. Surg."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb1090","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1095","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","article-title":"Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism","volume":"84","author":"Elkoushy","year":"2014","journal-title":"Urology"},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9343(03)00201-8","article-title":"Predictive value of kidney stone composition in the detection of metabolic abnormalities","volume":"115","author":"Pak","year":"2003","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1115","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1120","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1125","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3174\/ajnr.A4425","article-title":"Dynamic 4D MRI for characterization of parathyroid adenomas: multiparametric analysis","volume":"36","author":"Nael","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1135","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00268-016-3514-1","article-title":"Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis","volume":"40","author":"Singh Ospina","year":"2016","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","article-title":"The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake","volume":"41","author":"Jorde","year":"2002","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1043-2760(98)00119-2","article-title":"Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism","volume":"10","author":"Nemeth","year":"1999","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/ijem.IJEM_292_19","article-title":"Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective","volume":"23","author":"Chandran","year":"2019","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/bs.acc.2020.06.005_bb1155","doi-asserted-by":"crossref","first-page":"184321","DOI":"10.1155\/2015\/184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data","volume":"2015","author":"Hedgeman","year":"2015","journal-title":"Int. J. Nephrol."},{"issue":"Suppl. 113","key":"10.1016\/bs.acc.2020.06.005_bb1160","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","volume":"17","author":"Galitzer","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"7120","key":"10.1016\/bs.acc.2020.06.005_bb1170","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1175","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","article-title":"Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers","volume":"71","author":"Brown","year":"1991","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0003-9861(73)90010-6","article-title":"The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus","volume":"154","author":"Tanaka","year":"1973","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited","volume":"25","author":"Llach","year":"1995","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 3","key":"10.1016\/bs.acc.2020.06.005_bb1200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/11.supp3.130","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"11","author":"Slatopolsky","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1205","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11914-018-0486-0","article-title":"CKD-MBD: from the pathogenesis to the identification and development of potential novel therapeutic targets","volume":"16","author":"Elias","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb1210","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201ctrade-off\u201d hypothesis","volume":"5","author":"Gutierrez","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.mnh.0000172717.49476.80","article-title":"Role of fibroblast growth factor 23 in health and in chronic kidney disease","volume":"14","author":"Fukagawa","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1220","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1225","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb1235","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1240","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","volume":"78","author":"Krajisnik","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1245","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1250","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1523-1755.2000.00370.x","article-title":"Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism","volume":"58","author":"Yano","year":"2000","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1260","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1265","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+\u2212sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"14","key":"10.1016\/bs.acc.2020.06.005_bb1270","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","volume":"58","author":"Kestenbaum","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/1744-9987.12685","article-title":"Emerging association between parathyroid hormone and anemia in hemodialysis patients","volume":"22","author":"Tanaka","year":"2018","journal-title":"Ther. Apher. Dial."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1280","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 102","key":"10.1016\/bs.acc.2020.06.005_bb1285","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.ki.5001599","article-title":"Circulating PTH molecular forms: what we know and what we don't","volume":"70","author":"D'Amour","year":"2006","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1290","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/endo.142.4.8093","article-title":"Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH\/PTH-related peptide receptor","volume":"142","author":"Nguyen-Yamamoto","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1300","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2215\/CJN.02830608","article-title":"Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1310","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials","volume":"68","author":"Palmer","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.acc.2020.06.005_bb1315","first-page":"CD005633","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.acc.2020.06.005_bb1320","first-page":"CD008175","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1325","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb1330","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ndt\/gfg451","article-title":"Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism","volume":"18","author":"Okuno","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"15","key":"10.1016\/bs.acc.2020.06.005_bb1335","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb1340","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ndt\/gft417","article-title":"Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects","volume":"29","author":"Martin","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1350","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1355","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1360","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2215\/CJN.10390917","article-title":"Parathyroidectomy in the management of secondary hyperparathyroidism","volume":"13","author":"Lau","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1365","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1370","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.surg.2007.06.015","article-title":"Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism","volume":"142","author":"Costa-Hong","year":"2007","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1375","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00268-006-0693-1","article-title":"Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism","volume":"31","author":"Trombetti","year":"2007","journal-title":"World J. Surg."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1380","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1385","first-page":"412","article-title":"Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism","volume":"7","author":"Giangrande","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. 3","key":"10.1016\/bs.acc.2020.06.005_bb1390","first-page":"iii31","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. 3","key":"10.1016\/bs.acc.2020.06.005_bb1395","first-page":"iii47","article-title":"Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism","volume":"18","author":"Nakanishi","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1400","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1405","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","volume":"67","author":"Hernandez","year":"2005","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1410","first-page":"287","article-title":"Long-term use of cinacalcet in kidney transplant recipients with hypercalcemic secondary hyperparathyroidism: a single-center prospective study","volume":"16","author":"Zavvos","year":"2018","journal-title":"Exp. Clin. Transplant."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1415","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.transproceed.2016.01.044","article-title":"Treatment of persistent hypercalcemia and hyperparathyroidism with cinacalcet after successful kidney transplantation","volume":"48","author":"Wazna-Jablonska","year":"2016","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00423-019-01755-4","article-title":"Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis","volume":"404","author":"Dulfer","year":"2019","journal-title":"Langenbecks Arch. Surg."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1425","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1430","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/bs.acc.2020.06.005_bb1435","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/bs.acc.2020.06.005_bb1440","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1445","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/bs.acc.2020.06.005_bb1450","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1455","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/bs.acc.2020.06.005_bb1460","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2008.03408.x","article-title":"High third generation\/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation\/second generation PTH ratio in patients with primary hyperparathyroidism","volume":"70","author":"Caron","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1465","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2265.2005.02286.x","article-title":"Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery","volume":"62","author":"Rakel","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"8","key":"10.1016\/bs.acc.2020.06.005_bb1470","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2009-2791","article-title":"The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma","volume":"95","author":"Cavalier","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/bs.acc.2020.06.005_bb1475","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2013-3730","article-title":"The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform","volume":"99","author":"Cavalier","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/bs.acc.2020.06.005_bb1480","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrendo.2012.102","article-title":"Diagnosis and management of parathyroid cancer","volume":"8","author":"Schulte","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/bs.acc.2020.06.005_bb1485","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2011.04021.x","article-title":"Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation","volume":"74","author":"Caron","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"9","key":"10.1016\/bs.acc.2020.06.005_bb1490","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/S0021-9258(18)91041-0","article-title":"Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18","volume":"259","author":"Frelinger","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/bs.acc.2020.06.005_bb1495","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1210\/jc.2013-2139","article-title":"Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients","volume":"98","author":"Tepel","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4\u20135","key":"10.1016\/bs.acc.2020.06.005_bb1500","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000350149","article-title":"Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients","volume":"37","author":"Hocher","year":"2013","journal-title":"Kidney Blood Press. Res."},{"issue":"7","key":"10.1016\/bs.acc.2020.06.005_bb1505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress\u2014do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1510","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1373\/clinchem.2009.137323","article-title":"Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants","volume":"56","author":"Lopez","year":"2010","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/bs.acc.2020.06.005_bb1515","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1373\/clinchem.2009.134643","article-title":"Quantification of serum 1\u201384 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry","volume":"56","author":"Kumar","year":"2010","journal-title":"Clin. Chem."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242320300883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242320300883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:42:09Z","timestamp":1758742929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242320300883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128244159"],"references-count":302,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2020.06.005","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}